DANAHER CORP. Registered Shares logo

DANAHER CORP. Registered Shares (DAP)

Market Open
11 Feb, 07:00
196. 30
-2.74
-1.38%
178.45B Market Cap
28.65 P/E Ratio
1.08% Div Yield
158 Volume
7.58 Eps
199.04
Previous Close
Day Range
196.26 196.58
Year Range
196.26 258.05
Earnings results expected in 69 days

Summary

DAP trading today lower at €196.3, a decrease of 1.38% from yesterday's close, completing a monthly decrease of -11.38% or €25.2. Over the past 12 months, DAP stock lost -11.38%.
DAP pays dividends to its shareholders, with the most recent payment made on Jan 31, 2025. The next estimated payment will be in In 2 months on Apr 30, 2025 for a total of €0.27.
The last earnings report, released on Jan 28, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports. The next scheduled earnings report is due on Apr 21, 2025.
The stock of the company had never split.
The company's stock is traded on 11 different exchanges and in various currencies, with the primary listing on XBER (EUR).
Want to track DAP and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

DAP Chart

FAQ

What Is the DANAHER CORP. Registered Shares(DAP) Stock Price Today?

The DAP stock price today is €196.30.

What Stock Exchange Does DANAHER CORP. Registered Shares Trade On?

DANAHER CORP. Registered Shares is listed and trades on the NYSE.

What Is the Stock Symbol for DANAHER CORP. Registered Shares?

The stock symbol for DANAHER CORP. Registered Shares is "DAP".

Does DANAHER CORP. Registered Shares Pay Dividends? What's The Current Dividend Yield?

DAP is not paying dividends to its shareholders.

What Is the DANAHER CORP. Registered Shares Market Cap?

As of today, DANAHER CORP. Registered Shares market cap is 178.45B.

What is DANAHER CORP. Registered Shares Earnings Per Share?

The DANAHER CORP. Registered Shares EPS is 0.

What Is the Next DANAHER CORP. Registered Shares Earnings Date?

DANAHER CORP. Registered Shares will release its next earnings report on Apr 21, 2025.

Did DANAHER CORP. Registered Shares had any splits?

No, DANAHER CORP. Registered Shares has never had a stock split.

DANAHER CORP. Registered Shares Profile

Diagnostics & Research Industry
Healthcare Sector
Mr. Steven M. Rales CEO
XBER Exchange
US2358511028 ISIN
US Country
61,000 Employees
27 Dec 2024 Last Dividend
2 Oct 2023 Last Split
5 Jan 1979 IPO Date

Overview

Danaher Corporation is a global powerhouse in the design, manufacturing, and marketing of a vast array of professional, medical, industrial, and commercial products and services. With its inception in 1969 and a significant rebranding in 1984, where it transitioned from Diversified Mortgage Investors, Inc. to Danaher Corporation, the company has established a formidable presence in various sectors. Headquartered in Washington, D.C., Danaher stands out through its commitment to innovation, excellence, and enhancing the quality of life worldwide.

Products and Services

  • Biotechnology: Danaher's biotechnology segment is a provider of bioprocess technologies, consumables, and services enhancing the development and manufacture of therapeutics. This includes cell line and cell culture media development, chromatography resins, filtration technologies, aseptic fill-finish solutions, single-use hardware, and comprehensive services aimed at setting up full manufacturing suites.
  • Life Sciences: This segment delivers a wide range of products including mass spectrometers, flow cytometry, genomics solutions, lab automation instruments, centrifugation, liquid handling automation instruments, antibodies and reagents, particle counting and characterization tools, microscopes, and protein consumables. Among the notable brands under the Life Sciences segment are ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX, each providing specialized products for genomic medicines and industrial filtration.
  • Diagnostics: Danaher’s diagnostics sector offers a comprehensive range of chemistry, immunoassay, microbiology, automation systems, molecular diagnostics, acute care, and pathology diagnostics products. Aimed at hospitals, physicians' offices, reference laboratories, and other critical care settings, this segment ensures the delivery of clinical instruments, reagents, consumables, software, and dedicated services to support critical diagnostics.

Contact Information

Address: 2200 Pennsylvania Avenue, North West, Washington, DC, United States, 20037-1701
Phone: 202 828 0850